Abstract:OBJECTIVE:To investigate the effect of magnetic doxorubicin liposome (MDL) in the targeting treatment of nude mice bearing colon cancer.METHODS:Human colon cancer line LoVo cells were implanted hypodermically into nude mouse. Two weeks after the mouse was killed and the tumor was taken out and cut into small pieces to be retransplanted into nude mice so as to establish an experimental model. MDL was prepared by reverse-phase evaporation method. The particle size and structure of MDL were evaluated. Eighteen nude mice with colon cancer were divided into 3 groups of 3 mice: free DOX group, MDL (-) group (no magnetic field was added to the tumor surface), and MDL (+) group (magnetic field with the strength of 4,500 G was added). DOX of the dosage of 5 mg/kg was injected through the caudal vein in these 3 groups. Then the mice were killed 30 minutes after. Fluorescence spectrophotometry was used to examine the concentrations of DOX in the tissues and plasma. Another 36 nude mice with colon cancer were divided into 6 groups of 6 mice: normal saline group (as controls), DOX group, blank liposome group, magnetic liposome group, MDL (-) group (non-magnetic alloy was implanted into the tumor), and MDL (+) group (rare earth magnet was implanted into the tumor). The body weight, longest diameter of tumor, and short diameter vertical to the longest diameter were calculated regularly. The mice were killed 11 days after. The tumors were taken out to undergo staining and light microscopy. Flow cytometry was used to examine the apoptosis of tumor cells.RESULTS:The particle size of MDL was 230 nm and the magnetic particles (Fe(3)O(4)) were evenly distributed within the liposome. The DOX concentration in tumor tissue of the MDL (+) group was remarkably higher than those of the DOX and MDL (-) groups (both P < 0.05). The DOX concentration in heart and kidney of the DOX group were higher than those of the other 2 groups, and the plasma DOX concentrations of the DOX group was significantly lower than those of the other groups (all P < 0.05). The growth speed of tumor in the MDL (+) group was significantly lower, and the tumor weight was significantly less than in other groups.CONCLUSION:Magnetic doxorubicin liposome, as a carrier of anticancer drug, has a good targeting function toward the magnetite and has a significant anticancer effect.

Study on the Application of Doxorubicin-Loaded Magnetic Nanodrugs in Targeted Therapy of Liver Cancer

Actively Targeted Magnetothermally Responsive Nanocarriers/Doxorubicin for Thermochemotherapy of Hepatoma.

Doxorubicin-Loaded Dextran-Modified GoldMag Nanoparticles for Targeting Hepatocellular Carcinoma.

The Construction Of The Novel Magnetic Prodrug Fe3o4@Dox And Its Antagonistic Effects On Hepatocarcinoma With Low Toxicity

Precision Treatment of Colon Cancer Using Doxorubicin-Loaded Metal-Organic-Framework-Coated Magnetic Nanoparticles

Animal Experiment on Anti-Tumor Activity of Magnetic Nanocarrier and Doxorubicin with Target Simple External Magnetic Fields

Targeted Drug Delivery for Liver Cancer of Rat Using Magnetic Chitosan Nanoparticles Absorbed with Doxorubicin

Janus "Nano-Bullets" for Magnetic Targeting Liver Cancer Chemotherapy.

Enhanced Synergism of Thermo-chemotherapy For Liver Cancer with Magnetothermally Responsive Nanocarriers

Synergistic Pro-Apoptotic Effect of a Cyclic RGD Peptide-Conjugated Magnetic Mesoporous Therapeutic Nanosystem on Hepatocellular Carcinoma HepG2 Cells

Biocompatibility and Toxicity of Polylactic Acid/Ferrosoferric Oxide Nanomagnetic Microsphere

Fe-Mediated Self-Assembled Nanodrug for Tumor Microenvironment Activated Synergistic Ferroptosis-Based-Chemodynamic/Chemo Therapy and Magnetic Resonance Imaging

Visual Targeted Therapy of Hepatic Cancer Using Homing Peptide Modified Calcium Phosphate Nanoparticles Loading Doxorubicin Guided by T1 Weighted MRI

[Targeting Therapy of Magnetic Doxorubicin Liposome in Nude Mice Bearing Colon Cancer].

Co-Encapsulation of Magnetic Fe3o4 Nanoparticles and Doxorubicin into Biodegradable Plga Nanocarriers for Intratumoral Drug Delivery

MRI-guided targeting delivery of doxorubicin with reduction-responsive lipid-polymer hybrid nanoparticles.

Dextran-coated Superparamagnetic Nanoparticles As Potential Cancer Drug Carriers in Vivo.

Targeting Therapy of Magnetic Doxorubicin Stealth Liposome on Human Gastric Cancer Xenografts in Nude Mice

High Drug Loading and Ph-Responsive Targeted Nanocarriers from Alginate-Modified SPIONs for Anti-Tumor Chemotherapy.

Powerful Inner/outer Controlled Multi-Target Magnetic Nanoparticle Drug Carrier Prepared by Liquid Photo-Immobilization.

Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin.